ADO and neoplasm: The accumulation of extracellular ADO, followed by engagement of G-protein-coupled ADO receptors (A1, A2A, A2B, and A3) (7) on tumor-reactive NK cells has emerged a highly immunosuppressive mechanism driving tumor evasion (8).